Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-7.35	34.11	36.82
Graham Fair Price	66.18	163.95	98.66
PEG	-84.30	0.05	-0.31
Price/Book	0.47	1.42	1.41
Price/Cash Flow	-87.57	77.10	620.19
Prices/Earnings	-60.89	8.09	20.67
Price/Sales	-5.95	1.13	1.20
Price/FCF	-87.57	77.10	620.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.16	0.17	0.17
Operating Margin	-1.46	0.06	0.06
ROA	165.77	0.01	< 0.005
ROE	0.02	0.04	156.90
ROIC	0.02	0.02	10.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.42	-93.87
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.09	0.09	-0.57
EPS QOQ	-0.67	1.67	149.06
FCF QOQ	1.42	7.34	416.58
Revenue QOQ	0.04	0.10	157.41
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	52.57	48.32	-8.08
Days Sales Outstanding (DSO)	13.33	9.67	-27.49
Inventory Turnover	1.71	1.86	8.79
Debt/Capitalization	0.61	0.59	-1.97
Quick Ratio	0.21	0.18	-17.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	159.02	164.87	3.68
Cash	2.54	1.77	-30.49
Capex	-3.23	-5.17	-60.36
Free Cash Flow	0.36	3.04	737.89
Revenue	186.85	206.95	10.76
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.06	1.06	-0.30
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.10	17.63	-7.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating